Microbicide Trials Network

MTN-003 (VOICE) News Releases


New results from VOICE associates tenofovir gel use with lower HSV-2 risk in women

28-October-2014

 

First Comparison Between Injectable Contraceptives DMPA and NET-EN Suggests Some Women Using DMPA Were at Higher Risk of Acquiring HIV

4-March-2014

 

Behavioral Measures of Product Use Didn’t Measure Up in VOICE HIV Prevention Trial, Report the Study’s Researchers

4-March-2014

 

Daily HIV Prevention Approaches Didn’t Work for African Women in the VOICE Study

Mar 4, 2013

  

Microbicide Trials Network Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women

Nov 25, 2011

    

Microbicide Trials Network Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women

Sep 28, 2011

 

VOICE Study will Continue as it Considers What Action to Take After Results of Two Trials

Jul 13, 2011

 

HIV Prevention Trial Milestone: VOICE Study Completes Enrollment of 5,000 Women

Jun 6, 2011

 

Microbicide Trials Network Statement on the status of VOICE Study following announcement to close the FEM-PrEP trial

Apr 18, 2011

 

Trial shows ARVs can prevent HIV in men who have sex with men, making VOICE study in women more important than ever

Nov 23, 2010

 

Results of CAPRISA 004 a turning point for HIV prevention, say MTN researchers conducting VOICE

Jul 19, 2010

     

VOICE Study, a major HIV prevention trial for women, is launched in Zimbabwe

Sep 16, 2009

  

HIV prevention trial of ARV-based strategies to begin next month

Jul 20, 2009